title: Conversion to sirolimus after kidney and liver transplantation: indications and outcomes.
authors.affiliation: Department of Transplantation and Liver Surgery, Sahlgrenska University Hospital, Gothenburg, Sweden. lars.wramner@spray.se
authors.forename: L
authors.initials: L
authors.lastname: Wramner
authors.forename: G
authors.initials: G
authors.lastname: Norden
authors.forename: G
authors.initials: G
authors.lastname: Herlenius
authors.forename: S
authors.initials: S
authors.lastname: Friman
authors.forename: M
authors.initials: M
authors.lastname: Olausson
authors.forename: L
authors.initials: L
authors.lastname: Bäckman
mesh_terms: D000328:Adult; D000368:Aged; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D016031:Liver Transplantation / Q000276:immunology* / Q000473:pathology; D008875:Middle Aged; D020123:Sirolimus / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D007166:Immunosuppressive Agents; D020123:Sirolimus